MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
4.540
+0.220
+5.09%
Closed 15:58 02/13 EST
OPEN
4.400
PREV CLOSE
4.320
HIGH
4.590
LOW
4.220
VOLUME
38.96K
TURNOVER
--
52 WEEK HIGH
46.60
52 WEEK LOW
3.356
MARKET CAP
5.94M
P/E (TTM)
-0.0035
1D
5D
1M
3M
1Y
5Y
1D
Can-Fite BioPharma Wins Canadian Patent Allowance for Namodenoson Obesity Use
TipRanks · 4d ago
Can-Fite BioPharma receives Canadian patent allowance for namodenoson
TipRanks · 4d ago
Can-Fite BioPharma Secures Canadian Patent Allowance For A3 Adenosine Receptor Ligand Targeting Fat Loss
Benzinga · 4d ago
Can-Fite BioPharma Receives Canadian Patent Allowance for Namodenoson as Anti-Obesity Therapy
Reuters · 4d ago
Can-Fite BioPharma erhält kanadische Patenterlaubnis für Namodenoson als Anti-Obesitas-Therapie
Reuters · 4d ago
Weekly Report: what happened at CANF last week (0202-0206)?
Weekly Report · 4d ago
Can-Fite Reports Successful Liver Transplant After Compassionate Use of Namodenoson
TipRanks · 02/05 12:27
Can-Fite announces patient with liver cirrhosis treated with Namodenoson
TipRanks · 02/05 12:17
More
About CANF
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.